Keywords: santherha, completes, mbo, graffinity, santhera, pharmaceuticals, ag

Santherha completes MBO of Graffinity

Article | 16 January 2006

Santhera Pharmaceuticals AG, a Swiss-based specialty pharmaceutical firm with a focus on neuromuscular diseases, has completed a management buyout of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Go to company listing